Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5594457 | American Heart Journal | 2017 | 24 Pages |
Abstract
The LRT study will test feasibility of TAVR in low-risk patients with symptomatic severe aortic stenosis in the United States with either tricuspid or bicuspid native aortic valves. Enrollment commenced in 2016 and results are expected in 2018.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Toby MD, PhD, Rebecca MPH, Roshni MPH, Paul MD, Ron MD,